In practice, many experts believe the daily oral route may need a consistently high bioavailability to rival weekly shots
Tirzepatide enhances insulin secretion in a glucose-dependent manner, suppresses glucagon when glucose levels are elevated, and delays gastric emptying
Long-term safety studies monitor patients for extended periods after treatment initiation
The addition of GIP activation clearly enhanced metabolic outcomes compared to GLP-1 alone
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Lipase, amylase, liver-related markers, CBC, and nutritional tests are generally selected according to symptoms, history, and previous results rather than ordered automatically for everyone